Gemcitabine, which is currently prescribed as the first-line treatment for pancreatic cancer was shown to induce VMP-1 regulated autophagy mediated apoptosis in human PDAC cells [9]. This evidence concerns the gene VMP1 and familial pancreatic carcinoma.